- Release Date: 09/05/22 09:14
- Summary: FDA IND Approval for Phase 3 Study of DMX-200 in FSGS
- Price Sensitive: Yes
- Download Document 305.47KB
Ann: FDA IND Approval for Phase 3 Study of DMX-200 in FSGS
- There are more pages in this discussion • 49 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
63.5¢ |
Change
0.020(3.25%) |
Mkt cap ! $338.0M | |||
| Open | High | Low | Value | Volume |
| 62.0¢ | 65.0¢ | 62.0¢ | $703.8K | 1.102M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 21478 | 63.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 64.0¢ | 68794 | 5 |
View Market Depth
| Last trade - 10.31am 18/06/2024 (20 minute delay) ? |
|
|||||
|
Last
63.5¢ |
Change
0.020 ( 2.75 %) |
||||
| Open | High | Low | Volume | ||
| 63.0¢ | 65.0¢ | 62.5¢ | 639737 | ||
| Last updated 10.48am 18/06/2024 ? | |||||
| DXB (ASX) Chart |
